Stay updated with breaking news from Primary Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sara A. Hurvitz, MD, presents data from the phase 3 HER2CLIMB-02 study investigating tucatinib and trastuzumab emtansine in patients with previously treated HER2+ metastatic breast cancer.
But where mosunetuzumab/polatuzumab vedotin would fit among available options remains a question
Foods for your baby need to contain different nutrients for its growth and development. Know different forms in which foods can be introduced and enjoyed.
Investegate announcements from F. Hoffmann-La Roche Ltd, European Commission approves label expansion of Roche’s Hemlibra to include people with moderate haemophilia A in the EU
Investegate announcements from F. Hoffmann-La Roche Ltd, CHMP recommends expansion of EU label for Hemlibra to include people with moderate haemophilia A